GB1293507A - Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparation - Google Patents
Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparationInfo
- Publication number
- GB1293507A GB1293507A GB25055/71A GB2505571A GB1293507A GB 1293507 A GB1293507 A GB 1293507A GB 25055/71 A GB25055/71 A GB 25055/71A GB 2505571 A GB2505571 A GB 2505571A GB 1293507 A GB1293507 A GB 1293507A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxazolidinone
- derivatives
- phenyl
- carbamoyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LWTZRSAFMWXEDC-UHFFFAOYSA-N 2-oxo-1,3-oxazolidine-3-carboxamide Chemical class NC(=O)N1CCOC1=O LWTZRSAFMWXEDC-UHFFFAOYSA-N 0.000 title 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 230000001670 myorelaxant effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7010453A FR2081582A1 (en) | 1970-03-24 | 1970-03-24 | 3-1 substd-amino-carbonyl)-5-phenyl-oxa-zoli |
| FR7105295A FR2125175A2 (en) | 1971-02-17 | 1971-02-17 | 3-1 substd-amino-carbonyl)-5-phenyl-oxa-zoli |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1293507A true GB1293507A (en) | 1972-10-18 |
Family
ID=26215628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB25055/71A Expired GB1293507A (en) | 1970-03-24 | 1971-04-19 | Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparation |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US3754000A (enExample) |
| JP (1) | JPS5026543B1 (enExample) |
| BE (1) | BE763964A (enExample) |
| CA (1) | CA943553A (enExample) |
| CH (1) | CH513192A (enExample) |
| DE (1) | DE2111775A1 (enExample) |
| ES (1) | ES389473A1 (enExample) |
| GB (1) | GB1293507A (enExample) |
| IT (1) | IT1043850B (enExample) |
| LU (1) | LU62777A1 (enExample) |
| NL (1) | NL7103929A (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2315925A1 (fr) * | 1975-07-04 | 1977-01-28 | Nippon Chemiphar Co | Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique |
| DE2538424C2 (de) * | 1975-08-29 | 1983-01-05 | Nordmark-Werke Gmbh, 2000 Hamburg | 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat |
| DE2655369A1 (de) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
| IL61016A (en) * | 1979-10-03 | 1984-02-29 | Nippon Soda Co | 3-carboxamide(or carbothiamide)derivatives of oxazolidine and thiazolidine-2-one(or 2-thione),their preparation and acaricidal compositions containing them |
| US4501751A (en) * | 1980-12-22 | 1985-02-26 | American Cyanamid Company | Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby |
| US4522822A (en) * | 1980-12-22 | 1985-06-11 | American Cyanamid Company | Phenylethane derivatives and acid addition salts thereof for increasing lean meat deposition and/or improving lean meat to fat ratio in warm blooded animals |
| US5344936A (en) * | 1989-10-06 | 1994-09-06 | University Of South Carolina | Chalcogen-based chiral reagents for nuclear magnetic resonance detection of stereochemical assignments and enantiomeric ratios |
| WO2017106138A1 (en) | 2015-12-16 | 2017-06-22 | Merck Sharp & Dohme Corp. | Oxazolidinones as taro inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT277277B (de) * | 1967-07-10 | 1969-12-29 | Hoffmann La Roche | Verfahren zur herstellung von neuen sulfonylharnstoffderivaten |
-
1971
- 1971-03-08 BE BE763964A patent/BE763964A/xx unknown
- 1971-03-10 CH CH352371A patent/CH513192A/fr not_active IP Right Cessation
- 1971-03-11 LU LU62777D patent/LU62777A1/xx unknown
- 1971-03-11 DE DE19712111775 patent/DE2111775A1/de not_active Ceased
- 1971-03-22 US US00127049A patent/US3754000A/en not_active Expired - Lifetime
- 1971-03-22 IT IT67963/72A patent/IT1043850B/it active
- 1971-03-23 CA CA108,527*7A patent/CA943553A/en not_active Expired
- 1971-03-23 ES ES389473A patent/ES389473A1/es not_active Expired
- 1971-03-24 JP JP46016770A patent/JPS5026543B1/ja active Pending
- 1971-03-24 NL NL7103929A patent/NL7103929A/xx not_active Application Discontinuation
- 1971-04-19 GB GB25055/71A patent/GB1293507A/en not_active Expired
-
1973
- 1973-03-23 US US344359A patent/US3898241A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5026543B1 (enExample) | 1975-09-01 |
| CA943553A (en) | 1974-03-12 |
| ES389473A1 (es) | 1974-12-16 |
| US3754000A (en) | 1973-08-21 |
| CH513192A (fr) | 1971-09-30 |
| BE763964A (fr) | 1971-09-08 |
| DE2111775A1 (de) | 1971-10-14 |
| NL7103929A (enExample) | 1971-09-28 |
| IT1043850B (it) | 1980-02-29 |
| LU62777A1 (enExample) | 1971-10-13 |
| US3898241A (en) | 1975-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1252101A (enExample) | ||
| GB1374367A (en) | Propionamide derivative a method of making it and therapeutic compositions containing it | |
| GB1459065A (en) | Therapeutic thiophene derivatives | |
| GB1410511A (en) | Thiazole cardiovascular agnets | |
| GB1293507A (en) | Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparation | |
| GB1411583A (en) | Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them | |
| GB1298112A (en) | Phenyl acetyl guanidine derivatives | |
| GB1381320A (en) | Benzoxazole derivatives | |
| GB1394791A (en) | Diphenylalkyllactamimide derivatives | |
| GB1529403A (en) | Isoxazole derivative | |
| GB1262830A (en) | Novel sydnonimine derivative | |
| GB1458898A (en) | Ortho alkoxyanilides a process for their preparation and pharmaceutical compositions containing them | |
| GB1292787A (en) | Benzodioxane derivatives and pharmaceutical compositions containing them | |
| GB1340428A (en) | Benzothiadiazine derivatives their preparation and veterinary and pharmaceutical compositions containing them | |
| ES8400384A1 (es) | Procedimiento para la preparacion de derivados de carbaciclina. | |
| GB1263116A (en) | Chloramphenicol and thiamphenicol derivatives | |
| GB1514225A (en) | Paracetamol derivatives | |
| GB1198019A (en) | Process for the production of p-Aminobenzoic Acid Amides | |
| GB1434088A (en) | N-substituted glycinates a process for their preparation and pharmaceutical compositions containing them | |
| GB1488462A (en) | Acetamid-oximes their method of preparation and their application in therapeutics | |
| GB1468079A (en) | Ethanolamine derivatives | |
| GB1271054A (en) | Isoindoline and benzoisothiazoline derivatives, their preparation and pharmaceutical compositions containing them | |
| GB1324687A (en) | 3-amino-delta2-pyrazoline derivatives and process for the preparation thereof | |
| GB1467404A (en) | Heterocyclic carboxamido thiazolinyl and thiazinyl indoles | |
| GB1254270A (en) | Benzoxazepine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee | ||
| PCNP | Patent ceased through non-payment of renewal fee |